Drexel Morgan & Co. Abbott Laboratories Transaction History

Drexel Morgan & Co.

$538 Million
Q3 2024

A detailed history of Drexel Morgan & Co. transactions in Abbott Laboratories stock. As of the latest transaction made, Drexel Morgan & Co. holds 34,181 shares of ABT stock, worth $4.03 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

34,181

Previous 34,181 -0.0%

Holding current value

$4.03 Million

Previous $3.55 Million 9.72%

% of portfolio

0.72%

Previous 0.76%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$100.73 - $112.44 $55,099 - $61,504	547 Added 1.63%	34,181 $3.55 Million
Q1 2024 Apr 30, 2024	BUY	$109.52 - $120.96 $39,098 - $43,182	357 Added 1.07%	33,634 $3.82 Million
Q4 2023 Feb 08, 2024	BUY	$90.19 - $110.4 $31,837 - $38,971	353 Added 1.07%	33,277 $3.66 Million
Q4 2022 Feb 10, 2023	BUY	$95.06 - $111.52 $45,153 - $52,972	475 Added 1.46%	32,924 $3.62 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $37,914 - $41,944	-325 Reduced 0.99%	32,449 $3.83 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $5,131 - $6,232	-56 Reduced 0.17%	32,774 $3.57 Million
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $382 - $490	5 Added 0.02%	32,830 $3 Million
Q1 2020 May 08, 2020	BUY	$62.82 - $91.86 $644,972 - $943,126	10,267 Added 45.51%	32,825 $2.59 Million
Q4 2019 Feb 10, 2020	SELL	$78.51 - $87.4 $347,877 - $387,269	-4,431 Reduced 16.42%	22,558 $1.96 Million
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $4,664 - $5,058	57 Added 0.21%	26,989 $2.26 Million
Q2 2019 Aug 08, 2019	SELL	$72.88 - $85.0 $71,859 - $83,810	-986 Reduced 3.53%	26,932 $2.27 Million
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $44,698 - $54,040	675 Added 2.48%	27,918 $2.23 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $65,625 - $74,344	1,001 Added 3.81%	27,243 $1.97 Million
Q3 2018 Nov 09, 2018	SELL	$60.81 - $73.36 $4,378 - $5,281	-72 Reduced 0.27%	26,242 $1.93 Million
Q2 2018 Aug 09, 2018	SELL	$57.57 - $63.54 $86,585 - $95,564	-1,504 Reduced 5.41%	26,314 $1.61 Million
Q1 2018 May 10, 2018	BUY	$56.27 - $63.62 $15,249 - $17,241	271 Added 0.98%	27,818 $1.67 Million
Q4 2017 Feb 12, 2018	BUY	$53.68 - $57.47 $25,873 - $27,700	482 Added 1.78%	27,547 $1.57 Million
Q3 2017 Nov 13, 2017	SELL	$48.06 - $53.64 $37,919 - $42,321	-789 Reduced 2.83%	27,065 $1.44 Million
Q2 2017 Aug 14, 2017	BUY	N/A	27,854	27,854 $1.35 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Drexel Morgan & Co., based on Form 13F filings with the SEC.

News

Stay updated on Drexel Morgan & Co. with notifications on news.

Account